|
|
|
|
|
|
|
|
|
|
Over 4,000 research abstracts will be presented, including important research about advances in ovarian cancer treatment and care. Below is a preview of a few of the major studies of interest to ovarian cancer patients:
• Long-Term Treatment with Olaparib May Help Treat Recurrent Ovarian Cancer
• Screening Does Not Reduce Deaths from Ovarian Cancer for the General Population
• Cabozantinib Helps Manage Several Advanced Cancers (including Ovarian) and Shrink Bone Metastases
• Genetic Variations Identify Patients Sensitive to Nerve Damage from Chemotherapy
To hear in-depth information about these studies, listen to a podcast from ASCO leaders which is alsoASCO’s patient education website.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.